Inventor profile of:

Michael Mutz

City:

Freiburg

Country:

Germany

Published Applications:

27

Last publication date:

2015-10-08

Top Assignees for applications by Michael Mutz

The entities that hold a legal rights for patent applications filed by inventor Mutz Michael:

Recent patent applications by Mutz Michael

Michael Mutz from Freiburg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-10-08
US20150284364A1
Chemistry; metallurgy

SUBSTITUTED INDOLE DERIVATIVES

#2 | 2014-10-30
US20140323495A1
Human necessities

Stabilized Amorphous Forms of Imatinib Mesylate

#3 | 2014-08-21
US20140235722A1
Human necessities

Organic Compounds

#4 | 2014-02-20
US20140051766A1
Chemistry; metallurgy

Organic Compounds

#5 | 2013-11-07
US20130296556A1
Chemistry; metallurgy

Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic Acid Ethylamide and Formulations Comprising These Forms

#6 | 2013-10-10
US20130267572A1
Chemistry; metallurgy

Plymorphic forms of deferasirox (ICL670A)

#7 | 2013-08-29
US20130225598A1
Human necessities

Stabilized Amorphous Forms of Imatinib Mesylate

#8 | 2013-03-07
US20130060029A1
Chemistry; metallurgy

QUINAZOLINONE DERIVATIVES USEFUL AS VANILLOID ANTAGONISTS

#9 | 2013-01-24
US20130022672A1
Human necessities

Stabilized Amorphous Forms of Imatinib Mesylate

#10 | 2012-12-20
US20120322789A1
Chemistry; metallurgy

Organic compounds

#11 | 2012-08-09
US20120203007A1
Chemistry; metallurgy

Polymorphic forms of deferasirox (ICL670A)

#12 | 2012-07-05
US20120172592A1
Chemistry; metallurgy

Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

#13 | 2012-06-07
US20120142697A1
Chemistry; metallurgy

Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide

#14 | 2011-09-22
US20110229501A1
Chemistry; metallurgy

Organic compounds

#15 | 2011-09-08
US20110218248A1
Human necessities

Organic compounds

#16 | 2010-08-05
US20100197705A1
Chemistry; metallurgy

Quinazolinone derivatives useful as vanilloid antagonists

#17 | 2010-07-15
US20100178336A1
Human necessities

STABILIZED AMORPHOUS FORMS OF IMATINIB MESYLATE

#18 | 2010-06-24
US20100160393A1
Chemistry; metallurgy

Crystal form of epothilone B and use in pharmaceutical compositions

#19 | 2010-04-15
US20100093732A1
Chemistry; metallurgy

Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

#20 | 2010-03-04
US20100056590A1
Chemistry; metallurgy

Polymorphic forms of deferasirox (ICL670A)

#21 | 2010-03-04
US20100056481A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF ZOLEDRONIC ACID

#22 | 2009-12-31
US20090326239A1
Chemistry; metallurgy

FERMENTATIVE PREPARATION PROCESS FOR AND CRYSTAL FORMS OF CYTOSTATICS

#23 | 2008-10-30
US20080268040A1
Chemistry; metallurgy

Crystalline form F of Imatinib mesylate

#24 | 2008-10-16
US20080254116A1
Chemistry; metallurgy

Delta and epsilon crystal forms of Imatinib mesylate

#25 | 2008-10-09
US20080249104A1
Chemistry; metallurgy

Salt Forms of 4- (4-Methylpiperazin-1-Ylmethyl) -N- [4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl]- Benzamide

#26 | 2007-08-23
US20070197611A1
Chemistry; metallurgy

Fermentative preparation process for and crystal forms of cytostatics

#27 | 2006-09-05
US10459762
-

Fermentative preparation process for and crystal forms of cytostatics

InventorID:

52607 ⎘